Addiction and obesity share similar neurological pathways, both linked to compulsive behaviors and the brain's reward system. Research has highlighted the potential of GLP-1 receptor agonists, originally developed for diabetes, to help manage both appetite and addictive cravings. These medications, such as semaglutide, may regulate addictive behaviors by influencing reward circuits in the brain. However, they come with potential side effects, and their long-term effects are still under investigation.

In addition, a new compound, 5-Methoxy-2-aminoindane (MEAI), is being researched for its...

The Global Recovery Network is committed to providing valuable and relevant content for our community. 

To ensure our upcoming webinar series aligns with the needs and interests of our audience, we have developed this survey with U.S. based Faces and Voices of Recovery to determine which topics may be of most relevance. Our goal is to offer webinars that not only inform but also develop and build skills that support recovery, advocacy , and professional growth.
 
Your feedback is crucial in helping us design a webinar series that resonates with and benefits you.

Click here to complete a short...

Stimulants are a class of drugs that act on the central nervous system, increasing alertness, energy, and attention while elevating mood. They achieve these effects by enhancing the activity of neurotransmitters such as dopamine and norepinephrine in the brain.

Many stimulant-related hazards are linked to intensive, high-dose, or long-term usage. The mode of administration plays a significant moderating role; injecting stimulants and smoking crack cocaine or methamphetamine have been specifically associated with more problematic use behaviours. Even people who use stimulants sporadically or...